These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24272446)

  • 21. Using genetic diagnosis to determine individual therapeutic utility.
    Caskey CT
    Annu Rev Med; 2010; 61():1-15. PubMed ID: 19824818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Complement Ther Med; 2012; 20(1-2):93-9. PubMed ID: 22305254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs and regenerative medicine.
    Yang Z; Wu J
    DNA Cell Biol; 2007 Apr; 26(4):257-64. PubMed ID: 17465892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
    Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized medicine: progress and promise.
    Chan IS; Ginsburg GS
    Annu Rev Genomics Hum Genet; 2011; 12():217-44. PubMed ID: 21721939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiRNAs as biomarkers and therapeutic targets in cancer.
    Heneghan HM; Miller N; Kerin MJ
    Curr Opin Pharmacol; 2010 Oct; 10(5):543-50. PubMed ID: 20541466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer.
    Andorfer CA; Necela BM; Thompson EA; Perez EA
    Trends Mol Med; 2011 Jun; 17(6):313-9. PubMed ID: 21376668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA, immunogenetics, pharmacogenetics and personalized medicine.
    Charron D
    Vox Sang; 2011 Jan; 100(1):163-6. PubMed ID: 21175666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lexical fields of predictive and personalized medicine].
    Mathieu T; Bermont L; Boyer JC; Versuyft C; Evrard A; Cuvelier I; Couderc R; Peoc'h K
    Ann Biol Clin (Paris); 2012; 70(6):651-8. PubMed ID: 23207809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.
    Albulescu R; Neagu M; Albulescu L; Tanase C
    Expert Rev Mol Diagn; 2011 Jan; 11(1):101-20. PubMed ID: 21171925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.
    Farooqi AA; Nawaz A; Javed Z; Bhatti S; Ismail M
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):59-74. PubMed ID: 23229677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentially expressed microRNAs in pancreatic cancer stem cells.
    Jung DE; Wen J; Oh T; Song SY
    Pancreas; 2011 Nov; 40(8):1180-7. PubMed ID: 21785383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future perspectives of personalized oncology.
    Stambuk S; Sundov D; Kuret S; Beljan R; Andelinović S
    Coll Antropol; 2010 Jun; 34(2):763-9. PubMed ID: 20698168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical pharmacology: a paradigm for individualized medicine.
    Waldman SA; Kraft WK; Nelson TJ; Terzic A
    Biomark Med; 2009 Dec; 3(6):679-84. PubMed ID: 20477706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A revolution in genetics: changing medicine, changing lives.
    Bottles K
    Physician Exec; 2001; 27(2):58-63. PubMed ID: 11291222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Translation towards personalized medicine in Multiple Sclerosis.
    Miller A; Avidan N; Tzunz-Henig N; Glass-Marmor L; Lejbkowicz I; Pinter RY; Paperna T
    J Neurol Sci; 2008 Nov; 274(1-2):68-75. PubMed ID: 18789804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic procedures for paraffin-embedded tissues analysis in pharmacogenomic studies.
    Palmirotta R; De Marchis ML; Ludovici G; Ferroni P; Abete P; Guadagni F; Della-Morte D
    Methods Mol Biol; 2014; 1175():45-65. PubMed ID: 25150866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized medicine and ethics.
    Josko D
    Clin Lab Sci; 2014; 27(3):185-90. PubMed ID: 25219077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.